BULLETIN V2026-1820
KANE BIOTECH INC. ("KNE")
BULLETIN TYPE: Private Placement-Non-Brokered
BULLETIN DATE: May 27, 2026
TSX Venture Tier 2 Company
Financing Type: Non-Brokered Private Placement
Gross Proceeds: $1,160,000.00
Offering: 23,200,000 Listed Shares with 23,200,000 warrants attached
Offering Price: $0.05 per Listed Share
Warrant Exercise Terms: $0.06 per Listed Share for an 18-month period, subject to an acceleration
right
Commissions in Securities:
Shares Warrants
Finders (Aggregate) N/A 192,000
Commission Terms: Each non-transferable warrant is exercisable into a common share at $0.06 for an 18-month period, subject to an acceleration right
Disclosure: Refer to the company's news releases dated May 7, 2026 and May 26, 2026.
_______________________________________
|
|
